Morgan Stanley’s GMO Ultra-Short Income ETF GMOC Stock Holding History

Morgan Stanley’s Portfolio GMOC Stock Details GMOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Buy	+10,890	New	+$546K	﹤0.01%	5508

Other funds holding GMOC

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BPWM

BCS Private Wealth Management Rumson, New Jersey $332M AUM 23.51% 1-Year Est. Return

Morgan Stanley's GMOC Position: Q2 2026 in Review

Morgan Stanley opened a new position in GMO Ultra-Short Income ETF (GMOC) in Q2 2026: 10,890 shares worth $545K. The stake represents ﹤0.01% of the portfolio and ranks #5508 among its holdings.

6 funds tracked by Wall St. Rank hold GMOC as of Q2 2026.

Morgan Stanley held 10,890 shares of GMO Ultra-Short Income ETF worth $545K as of Q2 2026.
GMO Ultra-Short Income ETF was a new Morgan Stanley position in Q2 2026.
GMO Ultra-Short Income ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5508 holding.
6 funds tracked by Wall St. Rank held GMO Ultra-Short Income ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.